Charles B. Kemmler, MD
Assistant Professor of Clinical Emergency Medicine
Department: Emergency Medicine
Contact information
Penn Presbyterian Medical Center
Department of Emergency Medicine
51 N. 39th St.
Philadelphia, PA 19104
Department of Emergency Medicine
51 N. 39th St.
Philadelphia, PA 19104
Office:
Education:
PhD (Immunology)
University of Colorado/National Jewish Health, 2011.
MD (Medicine)
University of Colorado School of Medicine, 2016.
Permanent linkPhD (Immunology)
University of Colorado/National Jewish Health, 2011.
MD (Medicine)
University of Colorado School of Medicine, 2016.
Selected Publications
Jackson, E.M. and C.B. Kemmler: Young Man with Right Flank and Leg Swelling. Annals of Emergency Medicine 83(5): 490-491, May 2024.Kemmler CB, Sangal RB, Rothenberg C, Li SX, Shofer FS, Abella BS, Venkatesh AK, Foster SD: Delays in antibiotic redosing: Association with inpatient mortality and risk factors for delay. Am J Emerg Med. 46: 63-69, Aug 2021.
Kemmler C.B., Saleem, S.G., Ali, S., Samad, L., Haider, K.F., Jamal, M.I., Aziz, T., Maroof, Q., Dadabhoy, F.Z., Yasin, Z., Rybarczyk, M.M.: A 1-year training program in emergency medicine for physicians in Karachi, Pakistan: Evaluation of learner and program outcomes. AEM Educ Train 5(3): e10625, Jul 2021.
King TH, Kemmler CB, Guo Z, Mann D, Lu Y, Coeshott C, Gehring AJ, Bertoletti A, Ho ZZ, Delaney W, Gaggar A, Subramanian GM, McHutchison JG, Shrivastava S, Lee YJ, Kottilil S, Bellgrau D, Rodell T and D. Apelian: A whole recombinant yeast-based therapeutic vaccine elicits HBV X, S and Core specific T cells in mice and activates human T cells recognizing epitopes linked to viral clearance. PLoS One 9(7): e101904, Jul 2014.
Buhrman JD, Jordan KR, U’Ren L, Sprague J, Kemmler CB, and Slansky JE: Augmenting antitumor T-cell responses to mimotope vaccination by boosting with native tumor antigens. Cancer Research 73(1): 74-85, Jan 2013.
Kemmler CB, Clambey ET, Kedl RM, Slansky JE: Elevated tumor-association antigen expression suppresses variant peptide vaccine responses. J. Immunol 187(9): 4431-9, 2011.
Jordan KR, McMahan RH, Kemmler CB, Kappler JW, Slansky JE : Peptide vaccines prevent tumor growth by activating T cells that respond to native tumor antigens. Natl. Acad. Sci. 107(10): 4652-7, Mar 2010.
McWilliams JA, Sullivan RT, Jordan KR, McMahan RH, Kemmler CB, McDuffie M, Slansky JE: Age-dependent tolerance to an endogenous tumor-associated antigen. Vaccine 26: 1863-73, 2008.
Haller AA, Lauer GM, King TH, Kemmler CB, Fiolkoski V, Lu Y, Bellgrau D, Rodell, TC, Apelian D, Franzusoff A, Duke RC : Whole recombinant yeast-based immunotherapy induces potent T cell responses targeting HCV NS3 and Core proteins. Vaccine 25(8): 1452-63, Feb 2007.